July 2015 Cheat Sheet

Announcement describing Boehringer Ingelheim's idarucizumab for dabigatran reversal phase III trial results.

Discussion of the MTHFR polymorphisms and thrombosis riskk.

Summary of July, 2015 mixing study question about mixing study correction limits.

Dr. Siddartha Sharma asks about performing coagulation assays on EDTA specimens.